TheEdgeResearch
Home / Stocks / EBRCZ

EBR Systems, Inc. (EBRCZ)

OTC Healthcare Medical - Devices
$0.24 ▲ +0.00%
Market Cap
$150.7M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.52
52-Wk Range
0.17728-1.5
CEO
John Graham McCutcheon
Country
US
Currency
USD

EBR Systems, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Sunnyvale, CA, US. The stock last traded at $0.24, up 0.00% on the session, giving a market capitalisation of $150.7M. On trailing twelve-month figures it carries a trailing P/E of -2.20, a net margin of -1393.3%. Its beta of 0.52 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.20
Price / Sales
23.33
Price / Book
96.17
EV / EBITDA
-2.90
Gross margin
17.0%
Operating margin
-1322.7%
Net margin
-1393.3%
Return on equity
Debt / equity
6.24
Current ratio
4.48
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
135
IPO date
2023-08-31
Headquarters
Sunnyvale, CA, US
About EBR Systems, Inc.

EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle. This innovative approach aims to address and eliminate the typical difficulties associated with traditional wired leads, such as challenging insertion, unintended nerve activation, device displacement, complex removal procedures, and the need for frequent repositioning. The company was established in 2003 and operates from its headquarters in Sunnyvale, California.

Comparable companies

EBR Systems, Inc. is most often compared with the following Healthcare names:

AIHLFCKDXFCLAZFCSWYFIVEVFKDGTFKSRBFSSIITRSSFXVIPY
More research on EBRCZ
EBRCZ technical analysis EBRCZ TheEdge Score Compare against peers
Open full interactive analysis & DCF →